45
InterAct Therapeutics, Inc. raises $250K under Reg D
Company raise · Raising · DALLAS, TX · Form D filed 2026-07-21
First raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Isaac Chan | Dr. Chan is a director of the Issuer |
| Daniel Hargrove | Mr. Hargrove is the CEO and a director of the Issuer. |
Signed by Tyler Dove, By POA from Daniel Hargrove, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.